CO223 The Use of Artificial Intelligence to Guide Medication Dosage Is Associated with Improved Anemia Management and Lower Erythropoietin Stimulating Agents Consumption Among Dialysis Patients

M. Garbelli,F. Bellocchio, M.E. Baro Salvador, M. Chermisi,A. Rincon Bello,I. Berdud Godoy, S. Ortego Perez, K. Shkolenko, A. Sobrino Perez, D. Samaniego Toro, C. Apel, J. Petrovic,S. Stuard, C. Barbieri,F. Mari,L. Neri

Value in Health（2023）

引用 0|浏览4

暂无评分

摘要

The management of renal anemia remains challenging for nephrologists. The Anemia Control Model (ACM), a certified medical device based on Artificial Intelligence, assists nephrologists in optimizing dosage of erythropoiesis-stimulating agents (ESA) and iron for their patients. We evaluated the effectiveness of the ACM concerning hemoglobin (Hb) targets achievement and ESA inappropriate use.

查看译文

关键词

improved anemia management,erythropoietin,guide medication dosage,patients

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要